Quipt Home Medical [QIPT] vs Cencora [COR] Detailed Stock Comparison

Quipt Home Medical Corp.

NASDAQ
Loading...

Cencora Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Quipt Home Medical Corp. wins in 9 metrics, Cencora Inc. wins in 11 metrics, with 0 ties. Cencora Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Quipt Home Medical Corp. Cencora Inc. Better
P/E Ratio (TTM) 493.00 37.46 Cencora Inc.
Price-to-Book Ratio 1.59 31.84 Quipt Home Medical Corp.
Debt-to-Equity Ratio 102.33 472.58 Quipt Home Medical Corp.
PEG Ratio -14.79 2.62 Cencora Inc.
EV/EBITDA 6.41 13.93 Quipt Home Medical Corp.
Profit Margin (TTM) -4.03% 0.50% Cencora Inc.
Operating Margin (TTM) 1.54% 1.18% Quipt Home Medical Corp.
EBITDA Margin (TTM) 1.54% 1.18% Quipt Home Medical Corp.
Return on Equity -9.31% 133.47% Cencora Inc.
Return on Assets (TTM) -0.83% 3.33% Cencora Inc.
Free Cash Flow (TTM) $25.34M $3.21B Cencora Inc.
Dividend Yield N/A 0.64% N/A
1-Year Return 57.33% -7.51% Quipt Home Medical Corp.
Price-to-Sales Ratio (TTM) 0.61 0.19 Cencora Inc.
Enterprise Value $279.42M $69.11B Cencora Inc.
EV/Revenue Ratio 1.06 0.21 Cencora Inc.
Gross Profit Margin (TTM) 71.88% 3.58% Quipt Home Medical Corp.
Revenue per Share (TTM) $6 $1,680 Cencora Inc.
Earnings per Share (Diluted) $-0.23 $8.34 Cencora Inc.
Beta (Stock Volatility) 0.50 0.72 Quipt Home Medical Corp.
Short % of Float 2.01% 3.01% Quipt Home Medical Corp.

Quipt Home Medical Corp. vs Cencora Inc. Stock Performance Analysis

Loading Price Chart...

QIPT
COR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Quipt Home Medical Corp.0.00%0.00%1.39%3.69%33.70%3.40%
Cencora Inc.-0.42%-2.19%-12.78%-28.93%-24.48%-21.85%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Quipt Home Medical Corp.57.33%-47.93%-53.21%-3.95%29.43%16.24%
Cencora Inc.-7.51%54.34%130.38%251.92%567.56%1,169.37%

Performance & Financial Health Analysis: Quipt Home Medical Corp. vs Cencora Inc.

MetricQIPTCOR
Market Information
Market Cap i$162.30M$60.57B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i330,1351,221,804
90 Day Avg. Volume i337,3051,464,685
Last Close$3.65$263.71
52 Week Range$1.35 - $3.65$244.82 - $377.54
% from 52W High0.00%-30.15%
All-Time High$32.80 (Apr 20, 2015)$377.53 (Nov 25, 2025)
% from All-Time High-88.87%-30.15%
Growth Metrics
Quarterly Revenue Growth0.32%0.06%
Quarterly Earnings Growth0.32%0.15%
Financial Health
Profit Margin (TTM) i-0.04%0.01%
Operating Margin (TTM) i0.02%0.01%
Return on Equity (TTM) i-0.09%1.33%
Debt to Equity (MRQ) i102.33472.58
Cash & Liquidity
Book Value per Share (MRQ)$2.29$9.81
Cash per Share (MRQ)$0.24$9.01
Operating Cash Flow (TTM) i$37.33M$4.29B
Levered Free Cash Flow (TTM) i$44.54M$3.46B
Dividends
Last 12-Month Dividend Yield iN/A0.64%
Last 12-Month Dividend iN/A$2.30

Valuation & Enterprise Metrics Analysis: Quipt Home Medical Corp. vs Cencora Inc.

MetricQIPT (Apr 08, 2026)COR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i493.0037.46
Forward P/E i182.5015.94
PEG Ratio i-14.792.62
Price to Sales (TTM) i0.610.19
Price to Book (MRQ) i1.5931.84
Market Capitalization
Market Capitalization i$162.30M$60.57B
Enterprise Value i$279.42M$69.11B
Enterprise Value Metrics
Enterprise to Revenue i1.060.21
Enterprise to EBITDA i6.4113.93
Risk & Other Metrics
Beta i0.500.72
Book Value per Share (MRQ) i$2.29$9.81

Financial Statements Comparison: Quipt Home Medical Corp. vs Cencora Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricQIPT (2025)COR (2025)
Revenue/Sales i245.36M321.33B
Cost of Goods Sold i68.18M309.85B
COGS % of Revenue i27.8%96.4%
Gross Profit i177.18M11.48B
Gross Margin i72.2%3.6%
Research & Development iN/AN/A
Operating Income (EBIT) i-1.94M3.93B
Operating Margin i-0.8%1.2%
EBITDA i47.83M5.05B
EBITDA Margin i19.5%1.6%
Pre-Tax Income i-10.34M2.26B
Pre-Tax Income % of Revenue i-4.2%0.7%
Income Tax i241,000690.52M
Income Tax % of Revenue i0.1%0.2%
Net Income (Profit) i-10.58M1.57B
Profit Margin i-4.3%0.5%

Balance Sheet & Liquidity Metrics

MetricQIPT (2025)COR (2025)
Cash & Equivalents i12.92M4.36B
Total Current Assets i78.35M52.24B
Total Current Assets % of Revenue i31.9%16.3%
Total Current Liabilities i74.71M57.82B
Total Current Liabilities % of Revenue i30.4%18.0%
Long-Term Debt i95.53M7.54B
Long-Term Debt % of Revenue i38.9%2.3%
Total Shareholders Equity i112.10M1.75B
Retained Earnings i-181.27M6.53B
Retained Earnings % of Revenue i-73.9%2.0%
Property, Plant & Equipment i77.84M0

Cash Flow Statement Comparison

MetricQIPT (2025)COR (2025)
Operating Cash Flow i36.49M2.91B
Operating Cash Flow % of Revenue i14.9%0.9%
Capital Expenditures i-11.12MN/A
Free Cash Flow i25.34M3.21B
FCF Margin i10.3%1.0%
Debt Repayment i-43.20M-133.45B
Common Stock Repurchase i-130,000-435.47M

Short Interest & Institutional Ownership Analysis

MetricQIPTCOR
Shares Short i698,6845.16M
Short Ratio i1.913.41
Short % of Float i2.01%3.01%
Shares Outstanding i44.03M194.52M
Float Shares i33.33M183.99M
% Held by Insiders i21.05%4.23%
% Held by Institutions i37.29%97.08%
% Held by Public i41.66%-1.31%

Dividend Analysis & Yield Comparison: Quipt Home Medical Corp. vs Cencora Inc.

MetricQIPTCOR
Last 12-Month Dividend iN/A$2.30
Last 12-Month Dividend Yield iN/A0.64%
3-Year Avg Annual Dividend iN/A$2.13
3-Year Avg Dividend Yield iN/A0.22%
3-Year Total Dividends iN/A$6.40
Ex-Dividend DateN/AFeb 13, 2026